Orange Book product · Generic (ANDA)
CARBIDOPA
CARBIDOPA
Generic (ANDA)ANDA 204763TE ABRX NOVEL LABS INC
At a glance
Oct 20, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 20, 2017
8 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
CARBIDOPA
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 204763
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CARBIDOPA
- —LODOSYNBrand (NDA)
NDA 017830 · ATON
- 2023CARBIDOPAGeneric (ANDA)
ANDA 217961 · REGCON HOLDINGS
- 2019CARBIDOPAGeneric (ANDA)
ANDA 211055 · AUROBINDO PHARMA
- 2018CARBIDOPAGeneric (ANDA)
ANDA 209910 · ZYDUS PHARMS
- 2016CARBIDOPAGeneric (ANDA)
ANDA 205304 · EDENBRIDGE PHARMS
- 2016CARBIDOPAGeneric (ANDA)
ANDA 204291 · ALVOGEN
- 2014CARBIDOPAGeneric (ANDA)
ANDA 203261 · ANI PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
